NCT06324344View on ClinicalTrials.gov

Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)

NATerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Chemotherapy-induced Peripheral NeuropathyPainNeuropathy
Interventions
DEVICE

High-Dose TENS

high-dose TENS device delivers 1 hour of TENS therapy per session.

DEVICE

Low-Dose TENS

low-dose TENS device delivers 6 minutes of TENS therapy per session.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

NeuroMetrix, Inc.
All Listed Sponsors
collaborator

NeuroMetrix, Inc.

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT06324344 - Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN) | Biotech Hunter | Biotech Hunter